Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis (Q34004492)

30 July 2017

Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis (English)

1 reference

30 July 2017

0 references

0 references

0 references

1 reference

1

Avraham Beigelman

1 reference

30 July 2017

Cassandra L Mikols

2

1 reference

30 July 2017

Sean P Gunsten

3

1 reference

30 July 2017

Carolyn L Cannon

4

1 reference

30 July 2017

Steven L Brody

5

1 reference

30 July 2017

Michael J Walter

6

1 reference

30 July 2017

30 June 2010

1 reference

30 July 2017

1 reference

30 July 2017

11

1 reference

30 July 2017

90

1 reference

https://scigraph.springernature.com/pub.10.1186/1465-9921-11-90

30 July 2017

0 references

cites work

Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Increase in pneumococcus macrolide resistance, United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Cytokine response after severe respiratory syncytial virus bronchiolitis in early life

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Effects of telithromycin in in vitro and in vivo models of lipopolysaccharide-induced airway inflammation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Diagnosis and management of bronchiolitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

The effect of telithromycin in acute exacerbations of asthma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Macrolides and airway inflammation in children

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Low-dose, long-term macrolide therapy in asthma: An overview

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Viral induction of a chronic asthma phenotype and genetic segregation from the acute response

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Effects of paramyxoviral infection on airway epithelial cell Foxj1 expression, ciliogenesis, and mucociliary function

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Erythromycin and diffuse panbronchiolitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Risk of primary infection and reinfection with respiratory syncytial virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906448

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Impact of respiratory virus infections on persons with chronic underlying conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Azithromycin attenuates airway inflammation in a noninfectious mouse model of allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

IL-12 p80-dependent macrophage recruitment primes the host for increased survival following a lethal respiratory viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Glycogen Synthase Kinase-3β Inhibition Attenuates Asthma in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-90

Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma

21 January 2018

1 reference

12 December 2020

Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice

1 reference

12 December 2020

Roxithromycin attenuates acid-induced cough and water-induced bronchoconstriction in children with asthma

1 reference

12 December 2020

Roxithromycin reduces the degree of bronchial hyperresponsiveness in children with asthma

1 reference

12 December 2020

Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: a preliminary report

1 reference

12 December 2020

The macrolide antibacterial roxithromycin reduces bronchial hyperresponsiveness and superoxide anion production by polymorphonuclear leukocytes in patients with asthma

1 reference

12 December 2020

Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-11-90

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference